Publication Information

{'id': 'https://openalex.org/W2390905470', 'doi': None, 'title': 'Clinical analysis of adverse reactions of ankylosing spondylitis patients treated by different TNF-inhibitors', 'display_name': 'Clinical analysis of adverse reactions of ankylosing spondylitis patients treated by different TNF-inhibitors', 'publication_year': 2013, 'publication_date': '2013-01-01', 'ids': {'openalex': 'https://openalex.org/W2390905470', 'mag': '2390905470'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-SHEY201312015.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4317411217', 'display_name': 'Deleted Journal', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5086972269', 'display_name': 'Zhou Lan-la', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I83519826', 'display_name': 'Nanjing Medical University', 'ror': 'https://ror.org/059gcgy73', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I83519826']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Zhou Lan-la', 'raw_affiliation_strings': ['Department of Rheumatology,the First Affiliated Hospital,Nanjing Medical University'], 'affiliations': [{'raw_affiliation_string': 'Department of Rheumatology,the First Affiliated Hospital,Nanjing Medical University', 'institution_ids': ['https://openalex.org/I83519826']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5086972269'], 'corresponding_institution_ids': ['https://openalex.org/I83519826'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11092', 'display_name': 'Spondyloarthritis Studies and Treatments', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11092', 'display_name': 'Spondyloarthritis Studies and Treatments', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus Research', 'score': 0.9853, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tnf-inhibitor', 'display_name': 'TNF inhibitor', 'score': 0.5849398}], 'concepts': [{'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.96159697}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.9509828}, {'id': 'https://openalex.org/C2777402515', 'wikidata': 'https://www.wikidata.org/wiki/Q52849', 'display_name': 'Ankylosing spondylitis', 'level': 2, 'score': 0.9425943}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.83608496}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8105403}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.7530987}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.6599841}, {'id': 'https://openalex.org/C2780868878', 'wikidata': 'https://www.wikidata.org/wiki/Q1660197', 'display_name': 'Immunogenicity', 'level': 3, 'score': 0.61131626}, {'id': 'https://openalex.org/C2779722408', 'wikidata': 'https://www.wikidata.org/wiki/Q1536078', 'display_name': 'TNF inhibitor', 'level': 4, 'score': 0.5849398}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46858355}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.44155142}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.352572}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.20930043}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-SHEY201312015.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4317411217', 'display_name': 'Deleted Journal', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.6}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'study': [2], 'immunologic': [3], 'mechanisms': [4], 'induced': [5], 'by': [6], 'different': [7, 29], 'TNF-inhibitors': [8, 30], 'in': [9, 70], 'ankylosing': [10, 20], 'spondylitis': [11, 21], 'treatment.': [12], 'Methods': [13], 'A': [14], 'total': [15], 'of': [16, 28, 34, 41], '180': [17], 'patients': [18, 35], 'with': [19, 51, 54, 58], 'received': [22], 'TNFα': [23], 'inhibitors': [24], 'were': [25, 36, 43, 49, 64], 'collected.': [26], 'Distribution': [27], 'and': [31, 56, 68, 76], 'adverse': [32, 61, 99], 'reactions': [33], 'observed.': [37], 'Results': [38], 'Three': [39], 'kinds': [40], 'TNFinhibitors': [42], 'used.': [44], 'Among': [45], 'the': [46, 85], 'patients,': [47], '50': [48], 'treated': [50], 'Infliximab;': [52], '50,': [53], 'Adalimumab;': [55], '80,': [57], 'Etanercept.': [59], 'The': [60, 79, 90], 'reaction': [62], 'rates': [63], '14%,': [65], '13%,': [66], '4%,': [67], '6%': [69], 'Infliximab,': [71], 'Etanercept(': [72, 74], 'domestic),': [73], 'imported),': [75], 'Adalimumab,': [77], 'respectively.': [78], 'humanized': [80], 'TNF-inhibitor': [81, 93], 'was': [82, 94], 'safer': [83], 'than': [84], 'human-mouse': [86, 91], 'chimeric': [87, 92], 'TNFinhibitor.': [88], 'Conclusion': [89], 'more': [95], 'likely': [96], 'to': [97, 105], 'induce': [98], 'reactions,': [100], 'which': [101], 'might': [102], 'be': [103], 'related': [104], 'its': [106], 'immunogenicity.': [107]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2390905470', 'counts_by_year': [], 'updated_date': '2024-12-08T13:10:13.003618', 'created_date': '2016-06-24'}